Because SARS-CoV-2 is present in respiratory secretions and spreads through aerosolized particles, all types of in-person sexual activity “probably” carry some risk for transmitting the virus that causes COVID-19, according to three doctors affiliated with Massachusetts General Hospital in Boston.
Abstinence is the lowest risk approach to sex during the pandemic, and masturbation is additional safe recommendation for patients, according to Jack Turban, M.D., M.H.S., Alex S. Keuroghlian, M.D., M.P.H. and Kenneth Mayer, M.D., writing in yesterday’s Annals of Internal Medicine. Keuroghlian and Mayer are also affliated with the Fenway Instittue in Boston.
They note, though, the lack of data about sexual transmission of SARS-CoV-2 in their “ideas and opinions” piece for the journal published by the American College of Physicians in Philadelphia. Turban, Keuroghlian, and Mayer reference two small studies that showed no detectable SARS-CoV-2 in semen or vaginal secretions, although they point to a third study that found evidence of the virus in 16% (6 of 38) of semen samples. The authors of that study, which was published on May 7 in the JAMA Network Open, say that “even if the virus cannot replicate in the male reproductive system, it may persist, possibly resulting from the privileged immunity of testes.”
Whether evidence of the presence of SARS-CoV-2 in semen means the infection can be transmitted vai semen is unknown, but the authors say “it would be prudent o consider semen as potentially infectious.” Their advice about SARS-Cov-2 in urine is the similar.
The trio of physicians also say that patients can be counseled to engage in sexual activity with partners remotely via the telephone or video chats but should also be warned about the risk of partners taking screenshots of conversation.
For those for whom abstinence from in-person sexual activity is “not achievable,” Turban, Keuroghlian and Mayer suggest that having sex with someone with whom they are self-quarantining is the best approach.
They also mention that antibody tests may play an important role in evaluating COVID-19 sexual risks and safe sex practices as it has with HIV. People who test positive for antibodies against SARS-CoV-2 may have relative immunity against contracting an infection. That immunity may, therefore, allow for “serosorting of individuals for sexual activity.” Safe sex, with respect to SARS-CoV-2 transmission, may be possible among those have tested positive for the antibodies, according to Turban, Keuroghlian and Mayer.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More